ROGERS CORP ROG

Healthcare SIC 2821 - Plastic Materials, Synth Resins & Nonvulcan Elastomers NYSE

Last close 127.82 2026-09-04
Market cap $2.28B 2026-03-31 share count
52-week range 75.14 - 169.00

Valuation FY2025 figures against the last close

P/S2.8x
P/E
P/FCF32.1x
EV/EBITDA
Dividend yield
Diluted EPS-3.40

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $810.8M$830.1M$908.4M$971.2M$932.9M$802.6M$898.3M$879.1M$821.0M$656.3M
Cost of revenue $554.0M$553.0M$601.3M$650.2M$583.8M$510.8M$584.0M$568.3M$502.5M$406.8M
Gross profit $256.8M$277.1M$307.1M$321.0M$349.1M$291.8M$314.3M$310.8M$318.6M$249.5M
R&D $28.1M$34.6M$35.7M$35.2M$29.9M$29.3M$31.7M$33.1M$29.5M$28.6M
SG&A $176.6M$193.4M$202.3M$218.8M$193.1M$182.3M$168.7M$164.0M$161.7M$139.3M
Operating income -$45.0M$24.9M$85.3M$144.4M$117.2M$67.3M$110.5M$112.7M$129.1M$80.9M
Interest expense $800.0K$800.0K$10.1M$9.5M$2.5M$7.1M$6.9M$6.6M$6.1M
Pre-tax income -$45.1M$34.3M$76.3M$140.4M$126.3M$68.5M$55.1M$110.6M$132.9M$82.3M
Income tax $16.7M$8.2M$19.7M$23.8M$18.2M$18.5M$7.8M$22.9M$52.5M$34.0M
Net income -$61.8M$26.1M$56.6M$116.6M$108.1M$50.0M$47.3M$87.7M$80.5M$48.3M
EPS, basic -3.401.403.046.215.772.682.554.774.432.68
EPS, diluted -3.401.403.036.155.732.672.534.704.342.65
Shares, diluted (wtd. avg.) $18.2M$18.6M$18.7M$19.0M$18.9M$18.7M$18.7M$18.7M$18.5M$18.2M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $197.0M$159.8M$131.7M$235.9M$232.3M$191.8M$166.8M$167.7M$181.2M$227.8M
Receivables $130.6M$135.3M$161.9M$177.4M$163.1M$134.4M$122.3M$144.6M$140.6M$119.6M
Inventory $125.0M$142.3M$153.5M$182.4M$133.4M$102.4M$132.9M$132.6M$112.6M$91.1M
Total current assets $500.0M$493.9M$526.9M$659.9M$584.1M$474.2M$464.1M$485.8M$454.5M$458.4M
Property, plant and equipment $242.8M$179.6M$176.9M
Goodwill $303.4M$357.6M$359.8M$352.4M$370.2M$270.2M$262.9M$264.9M$237.1M$208.4M
Other intangibles $99.3M$110.3M$123.9M$133.7M$176.4M$118.0M$158.9M$177.0M$160.3M$136.7M
Total assets $1.43B$1.48B$1.52B$1.65B$1.60B$1.26B$1.27B$1.28B$1.13B$1.06B
Accounts payable $42.9M$48.1M$50.3M$57.3M$64.7M$36.0M$33.0M$40.3M$36.1M$28.4M
Short-term debt $0$3.7M
Total current liabilities $126.1M$123.5M$116.4M$142.5M$163.9M$111.5M$100.2M$107.2M$113.8M$101.2M
Long-term debt $0$30.0M$215.0M$190.0M$25.0M$123.0M$228.5M$131.0M$235.9M
Retained earnings $1.12B$1.18B$1.16B$1.10B$981.8M$873.7M$823.7M$776.4M$684.5M$591.3M
Total equity $1.20B$1.25B$1.26B$1.17B$1.12B$1.02B$933.9M$848.3M$766.6M$635.8M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $101.2M$127.1M$131.4M$129.5M$124.4M$165.1M$161.3M$66.8M$139.0M$117.0M
Depreciation and amortisation $43.3M$37.0M$37.7M$29.5M$29.0M$29.3M$31.4M$33.5M$29.3M$26.6M
Stock-based compensation $10.9M$15.1M$14.3M$11.8M$17.0M$13.5M$12.3M$11.2M$11.8M$11.3M
Capital expenditure $30.1M$56.1M$57.0M$116.8M$71.1M$40.4M$51.6M$47.1M$27.2M$18.1M
Investing cash flow -$14.8M-$45.6M-$47.9M-$113.1M-$238.6M-$40.4M-$49.0M-$167.4M-$78.3M-$151.8M
Financing cash flow -$53.9M-$50.1M-$190.3M-$10.1M$159.0M-$104.2M-$111.8M$88.7M-$113.2M$57.9M
Buybacks $52.4M$19.8M$0$25.0M$0$0$0$3.0M$0$8.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000084748-26-000007.

Others in SIC 2821

TickerCompanyMarket capP/ERevenue growth
DOW DOW INC. $21.22B -7.0%
DD DuPont de Nemours, Inc. $17.77B 1.9%
ALB ALBEMARLE CORP $14.90B -4.4%
EMN EASTMAN CHEMICAL CO $8.14B 17.4x -6.7%
HXL HEXCEL CORP /DE/ $6.96B -0.5%
AVNT AVIENT CORP $3.98B 48.8x 0.6%
PCT PureCycle Technologies, Inc. $1.28B
ASIX AdvanSix Inc. $471.2M 9.7x 0.3%